BMP7 Antikörper
-
- Target Alle BMP7 Antikörper anzeigen
- BMP7 (Bone Morphogenetic Protein 7 (BMP7))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BMP7 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)
- Aufreinigung
- Purified
- Immunogen
- BMP7 antibody was raised in rabbit using highly pure recombinant human BMP-7 as the immunogen.
- Top Product
- Discover our top product BMP7 Primärantikörper
-
-
- Applikationshinweise
-
ELISA: 0.5-2 µg/mL, Inhibition: 0.4-0.6 µg/mL, WB: 0.1-0.2 µg/mL
Optimal conditions should be determined by the investigator. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized from PBS, pH 7.2.
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.
-
- Target
- BMP7 (Bone Morphogenetic Protein 7 (BMP7))
- Andere Bezeichnung
- BMP7 (BMP7 Produkte)
- Hintergrund
- TGF beta family members are key modulators of cell proliferation, differentiation, matrix synthesis, and apoptosis. As implied by their name, BMPs initiate, promote, and regulate the development, growth and remodeling of bone and cartilage. In addition to this role, BMPs are also involved in prenatal development and postnatal growth, remodeling and maintenance of a variety of other tissues and organs. BMP-7, also known as osteogenic protein-1 or OP-1, is a potent bone inducing agent, which in the presence of appropriate osteoconductive carrier (e.g. collagen sponge or synthetic hydroxyapatite) can be used in the treatment of bone defects.
- Molekulargewicht
- 28.8 kDa (predicted detection band MW)
- Pathways
- Steroid Hormone Mediated Signaling Pathway, Stem Cell Maintenance
-